These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27894300)

  • 1. Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin.
    Burgy O; Bellaye PS; Causse S; Beltramo G; Wettstein G; Boutanquoi PM; Goirand F; Garrido C; Bonniaud P
    Respir Res; 2016 Nov; 17(1):162. PubMed ID: 27894300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic role of αB-crystallin inhibition in pleural and subpleural fibrosis.
    Bellaye PS; Burgy O; Colas J; Fabre A; Marchal-Somme J; Crestani B; Kolb M; Camus P; Garrido C; Bonniaud P
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):244-52. PubMed ID: 25032514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
    Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
    J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
    Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
    J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
    Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
    Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis.
    Liu F; Yu F; Lu YZ; Cheng PP; Liang LM; Wang M; Chen SJ; Huang Y; Song LJ; He XL; Xiong L; Xin JB; Ma WL; Ye H
    Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118806. PubMed ID: 32739525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis.
    Hamanaka RB; Nigdelioglu R; Meliton AY; Tian Y; Witt LJ; O'Leary E; Sun KA; Woods PS; Wu D; Ansbro B; Ard S; Rohde JM; Dulin NO; Guzy RD; Mutlu GM
    Am J Respir Cell Mol Biol; 2018 May; 58(5):585-593. PubMed ID: 29019702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF/Src signaling mediated pleural barrier damage and increased permeability contributes to subpleural pulmonary fibrosis.
    Lu YZ; Liang LM; Cheng PP; Xiong L; Wang M; Song LJ; Yu F; He XL; Xiong L; Wang XR; Xin JB; Ye H; Ma WL
    Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L990-L1004. PubMed ID: 33787325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis.
    Wang D; Gong L; Li Z; Chen H; Xu M; Rong R; Zhang Y; Zhu Q
    J Ethnopharmacol; 2021 Dec; 281():114522. PubMed ID: 34391863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.
    Smoktunowicz N; Alexander RE; Franklin L; Williams AE; Holman B; Mercer PF; Jarai G; Scotton CJ; Chambers RC
    Dis Model Mech; 2015 Sep; 8(9):1129-39. PubMed ID: 26138704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
    Yu W; Guo F; Song X
    Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
    Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
    Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
    Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles.
    Decologne N; Wettstein G; Kolb M; Margetts P; Garrido C; Camus P; Bonniaud P
    Eur Respir J; 2010 Jan; 35(1):176-85. PubMed ID: 19574324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
    Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
    Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
    Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
    François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
    J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.